Logo image of AXON

AXON ENTERPRISE INC (AXON) Stock Fundamental Analysis

NASDAQ:AXON - Nasdaq - US05464C1018 - Common Stock - Currency: USD

827.94  +9.34 (+1.14%)

After market: 827.21 -0.73 (-0.09%)

Fundamental Rating

5

Taking everything into account, AXON scores 5 out of 10 in our fundamental rating. AXON was compared to 65 industry peers in the Aerospace & Defense industry. AXON has an average financial health and profitability rating. AXON is valued quite expensive, but it does show an excellent growth. These ratings could make AXON a good candidate for growth investing.


Dividend Valuation Growth Profitability Health

Quickly go to:

6

1. Profitability

1.1 Basic Checks

In the past year AXON was profitable.
In the past year AXON had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: AXON reported negative net income in multiple years.
In the past 5 years AXON always reported a positive cash flow from operatings.
AXON Yearly Net Income VS EBIT VS OCF VS FCFAXON Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M 300M 400M

1.2 Ratios

AXON has a better Return On Assets (7.64%) than 83.08% of its industry peers.
AXON has a Return On Equity of 18.19%. This is amongst the best in the industry. AXON outperforms 87.69% of its industry peers.
Looking at the Return On Invested Capital, with a value of 0.91%, AXON is doing worse than 61.54% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for AXON is significantly below the industry average of 8.44%.
Industry RankSector Rank
ROA 7.64%
ROE 18.19%
ROIC 0.91%
ROA(3y)6.22%
ROA(5y)2.99%
ROE(3y)12.87%
ROE(5y)6.54%
ROIC(3y)3.12%
ROIC(5y)N/A
AXON Yearly ROA, ROE, ROICAXON Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 -5 10 -10 15

1.3 Margins

The Profit Margin of AXON (17.31%) is better than 96.92% of its industry peers.
AXON's Profit Margin has improved in the last couple of years.
AXON has a Operating Margin of 2.03%. This is in the lower half of the industry: AXON underperforms 61.54% of its industry peers.
With an excellent Gross Margin value of 59.83%, AXON belongs to the best of the industry, outperforming 90.77% of the companies in the same industry.
AXON's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 2.03%
PM (TTM) 17.31%
GM 59.83%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y155.54%
GM growth 3Y-1.64%
GM growth 5Y0.59%
AXON Yearly Profit, Operating, Gross MarginsAXON Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

More info and screens

6

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AXON is destroying value.
The number of shares outstanding for AXON has been increased compared to 1 year ago.
The number of shares outstanding for AXON has been increased compared to 5 years ago.
AXON has a better debt/assets ratio than last year.
AXON Yearly Shares OutstandingAXON Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
AXON Yearly Total Debt VS Total AssetsAXON Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B

2.2 Solvency

AXON has an Altman-Z score of 12.12. This indicates that AXON is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of AXON (12.12) is better than 90.77% of its industry peers.
AXON has a debt to FCF ratio of 5.53. This is a neutral value as AXON would need 5.53 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 5.53, AXON is in the better half of the industry, outperforming 66.15% of the companies in the same industry.
AXON has a Debt/Equity ratio of 0.68. This is a neutral value indicating AXON is somewhat dependend on debt financing.
AXON has a worse Debt to Equity ratio (0.68) than 64.62% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 5.53
Altman-Z 12.12
ROIC/WACC0.09
WACC10.06%
AXON Yearly LT Debt VS Equity VS FCFAXON Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.83 indicates that AXON has no problem at all paying its short term obligations.
The Current ratio of AXON (2.83) is comparable to the rest of the industry.
A Quick Ratio of 2.62 indicates that AXON has no problem at all paying its short term obligations.
AXON's Quick ratio of 2.62 is fine compared to the rest of the industry. AXON outperforms 78.46% of its industry peers.
Industry RankSector Rank
Current Ratio 2.83
Quick Ratio 2.62
AXON Yearly Current Assets VS Current LiabilitesAXON Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 39.55% over the past year.
AXON shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 41.41% yearly.
AXON shows a strong growth in Revenue. In the last year, the Revenue has grown by 59.79%.
Measured over the past years, AXON shows a very strong growth in Revenue. The Revenue has been growing by 31.44% on average per year.
EPS 1Y (TTM)39.55%
EPS 3Y36.34%
EPS 5Y41.41%
EPS Q2Q%22.61%
Revenue 1Y (TTM)59.79%
Revenue growth 3Y34.11%
Revenue growth 5Y31.44%
Sales Q2Q%31.01%

3.2 Future

The Earnings Per Share is expected to grow by 15.98% on average over the next years. This is quite good.
AXON is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 19.50% yearly.
EPS Next Y7.35%
EPS Next 2Y15.38%
EPS Next 3Y15.98%
EPS Next 5YN/A
Revenue Next Year28.07%
Revenue Next 2Y25.41%
Revenue Next 3Y23.13%
Revenue Next 5Y19.5%

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
AXON Yearly Revenue VS EstimatesAXON Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 2B 4B 6B
AXON Yearly EPS VS EstimatesAXON Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

AXON is valuated quite expensively with a Price/Earnings ratio of 134.84.
AXON's Price/Earnings is on the same level as the industry average.
AXON's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.15.
AXON is valuated quite expensively with a Price/Forward Earnings ratio of 105.78.
AXON's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. AXON is more expensive than 66.15% of the companies in the same industry.
AXON is valuated expensively when we compare the Price/Forward Earnings ratio to 21.60, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 134.84
Fwd PE 105.78
AXON Price Earnings VS Forward Price EarningsAXON Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, AXON is valued a bit more expensive than 66.15% of the companies in the same industry.
AXON's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 177.76
EV/EBITDA 567.17
AXON Per share dataAXON EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AXON does not grow enough to justify the current Price/Earnings ratio.
AXON has a very decent profitability rating, which may justify a higher PE ratio.
AXON's earnings are expected to grow with 15.98% in the coming years. This may justify a more expensive valuation.
PEG (NY)18.34
PEG (5Y)3.26
EPS Next 2Y15.38%
EPS Next 3Y15.98%

More info and screens

0

5. Dividend

5.1 Amount

AXON does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AXON ENTERPRISE INC

NASDAQ:AXON (6/30/2025, 8:00:01 PM)

After market: 827.21 -0.73 (-0.09%)

827.94

+9.34 (+1.14%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)05-07 2025-05-07/amc
Earnings (Next)08-04 2025-08-04/amc
Inst Owners81.97%
Inst Owner ChangeN/A
Ins Owners0.58%
Ins Owner Change6.13%
Market Cap64.46B
Analysts81.74
Price Target735.06 (-11.22%)
Short Float %2.01%
Short Ratio2.56
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)26.89%
Min EPS beat(2)8.51%
Max EPS beat(2)45.27%
EPS beat(4)4
Avg EPS beat(4)21.86%
Min EPS beat(4)8.51%
Max EPS beat(4)45.27%
EPS beat(8)8
Avg EPS beat(8)30.38%
EPS beat(12)12
Avg EPS beat(12)30.91%
EPS beat(16)16
Avg EPS beat(16)61.69%
Revenue beat(2)1
Avg Revenue beat(2)0.49%
Min Revenue beat(2)-0.39%
Max Revenue beat(2)1.38%
Revenue beat(4)3
Avg Revenue beat(4)1.48%
Min Revenue beat(4)-0.39%
Max Revenue beat(4)3.29%
Revenue beat(8)7
Avg Revenue beat(8)2.16%
Revenue beat(12)11
Avg Revenue beat(12)3.99%
Revenue beat(16)15
Avg Revenue beat(16)6.08%
PT rev (1m)8.35%
PT rev (3m)8.36%
EPS NQ rev (1m)2.21%
EPS NQ rev (3m)1.63%
EPS NY rev (1m)1.21%
EPS NY rev (3m)0.94%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)1.25%
Revenue NY rev (1m)0%
Revenue NY rev (3m)1.99%
Valuation
Industry RankSector Rank
PE 134.84
Fwd PE 105.78
P/S 24
P/FCF 177.76
P/OCF 143.22
P/B 25.22
P/tB 39.52
EV/EBITDA 567.17
EPS(TTM)6.14
EY0.74%
EPS(NY)7.83
Fwd EY0.95%
FCF(TTM)4.66
FCFY0.56%
OCF(TTM)5.78
OCFY0.7%
SpS34.5
BVpS32.83
TBVpS20.95
PEG (NY)18.34
PEG (5Y)3.26
Profitability
Industry RankSector Rank
ROA 7.64%
ROE 18.19%
ROCE 1.15%
ROIC 0.91%
ROICexc 1.81%
ROICexgc 2.96%
OM 2.03%
PM (TTM) 17.31%
GM 59.83%
FCFM 13.5%
ROA(3y)6.22%
ROA(5y)2.99%
ROE(3y)12.87%
ROE(5y)6.54%
ROIC(3y)3.12%
ROIC(5y)N/A
ROICexc(3y)5.69%
ROICexc(5y)N/A
ROICexgc(3y)6.38%
ROICexgc(5y)N/A
ROCE(3y)3.94%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5Y155.54%
GM growth 3Y-1.64%
GM growth 5Y0.59%
F-Score3
Asset Turnover0.44
Health
Industry RankSector Rank
Debt/Equity 0.68
Debt/FCF 5.53
Debt/EBITDA 15.6
Cap/Depr 155.29%
Cap/Sales 3.26%
Interest Coverage 250
Cash Conversion 406.32%
Profit Quality 77.97%
Current Ratio 2.83
Quick Ratio 2.62
Altman-Z 12.12
F-Score3
WACC10.06%
ROIC/WACC0.09
Cap/Depr(3y)192.5%
Cap/Depr(5y)286.11%
Cap/Sales(3y)4.12%
Cap/Sales(5y)5.78%
Profit Quality(3y)94.42%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)39.55%
EPS 3Y36.34%
EPS 5Y41.41%
EPS Q2Q%22.61%
EPS Next Y7.35%
EPS Next 2Y15.38%
EPS Next 3Y15.98%
EPS Next 5YN/A
Revenue 1Y (TTM)59.79%
Revenue growth 3Y34.11%
Revenue growth 5Y31.44%
Sales Q2Q%31.01%
Revenue Next Year28.07%
Revenue Next 2Y25.41%
Revenue Next 3Y23.13%
Revenue Next 5Y19.5%
EBIT growth 1Y-64.75%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year92.63%
EBIT Next 3Y47.68%
EBIT Next 5YN/A
FCF growth 1Y314.57%
FCF growth 3Y64.36%
FCF growth 5Y46.2%
OCF growth 1Y233.18%
OCF growth 3Y48.58%
OCF growth 5Y44.12%